下一个

自动播放

Kidney cancer: post-surgery sorafenib

0 意见 • 06/26/23
分享
嵌入
administrator
administrator
订户
0

Tim Eisen, MBBChir, PhD, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, describes the rationale and methodology behind the SORCE trial (NCT00492258) and what have we learned at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放